PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,230 | -23.8% | 40,084 | -0.6% | 0.10% | -22.4% |
Q2 2023 | $1,615 | +326.1% | 40,327 | +333.9% | 0.13% | +306.1% |
Q1 2023 | $379 | +5.6% | 9,294 | 0.0% | 0.03% | 0.0% |
Q4 2022 | $359 | -99.9% | 9,294 | +0.7% | 0.03% | -32.7% |
Q3 2022 | $491,000 | -8.9% | 9,231 | 0.0% | 0.05% | -2.0% |
Q2 2022 | $539,000 | -22.1% | 9,231 | +1.9% | 0.05% | -7.4% |
Q1 2022 | $692,000 | +28.9% | 9,057 | +1.5% | 0.05% | +28.6% |
Q4 2021 | $537,000 | +7.4% | 8,923 | 0.0% | 0.04% | 0.0% |
Q3 2021 | $500,000 | -7.7% | 8,923 | -0.1% | 0.04% | -2.3% |
Q2 2021 | $542,000 | -15.7% | 8,933 | -2.7% | 0.04% | -21.8% |
Q1 2021 | $643,000 | +31.2% | 9,181 | +12.1% | 0.06% | +17.0% |
Q4 2020 | $490,000 | -9.4% | 8,190 | -9.0% | 0.05% | -20.3% |
Q3 2020 | $541,000 | +27.9% | 8,998 | +11.7% | 0.06% | +15.7% |
Q2 2020 | $423,000 | -51.2% | 8,059 | -68.8% | 0.05% | -54.9% |
Q1 2020 | $866,000 | +189.6% | 25,813 | +290.6% | 0.11% | +276.7% |
Q4 2019 | $299,000 | – | 6,609 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |